Dennis Slamon
MD, PhD
Director, Revlon/UCLA Women's Cancer Research Program
👥Biography 个人简介
Dennis Slamon discovered that HER2 amplification drives aggressive breast cancer and developed trastuzumab (Herceptin), the first oncogene-targeted therapy approved for solid tumors. His work demonstrated that molecular characterization of tumors could identify patients who benefit from targeted agents, establishing the paradigm of biomarker-driven cancer treatment. Trastuzumab has transformed HER2-positive breast cancer from the most deadly to one of the most treatable subtypes.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Dennis Slamon 的研究动态
Follow Dennis Slamon's research updates
留下邮箱，当我们发布与 Dennis Slamon（University of California, Los Angeles）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment